Cargando…
Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways
Zoledronate is a standard treatment for preventing skeletal complications of osteoporosis and some types of cancer associated with bone metastases, but we little know whether the effect of zoledronate on metastasis of osteosarcoma. Here, we investigated the inhibitory effects of zoledronate on cell...
Autores principales: | Cheng, Hsin-Lin, Lin, Chiao-Wen, Yang, Jia-Sin, Hsieh, Ming-Ju, Yang, Shun-Fa, Lu, Ko-Hsiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891081/ https://www.ncbi.nlm.nih.gov/pubmed/26848867 http://dx.doi.org/10.18632/oncotarget.7138 |
Ejemplares similares
-
Towards Complete Sets of Farnesylated and Geranylgeranylated Proteins
por: Maurer-Stroh, Sebastian, et al.
Publicado: (2007) -
The alteration of RhoA geranylgeranylation and Ras farnesylation breaks the integrity of the blood–testis barrier and results in hypospermatogenesis
por: Zhu, Ruilou, et al.
Publicado: (2019) -
Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
por: Ory, B, et al.
Publicado: (2008) -
Effects of mevalonate kinase interference on cell differentiation, apoptosis, prenylation and geranylgeranylation of human keratinocytes are attenuated by farnesyl pyrophosphate or geranylgeranyl pyrophosphate
por: Li, Min, et al.
Publicado: (2020) -
Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo
por: Benetka, Wolfgang, et al.
Publicado: (2006)